These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12779282)

  • 1. Highly stabilized amorphous 3-bis(4-methoxyphenyl)methylene-2-indolinone (TAS-301) in melt-adsorbed products with silicate compounds.
    Kinoshita M; Baba K; Nagayasu A; Yamabe K; Azuma M; Houchi H; Minakuchi K
    Drug Dev Ind Pharm; 2003 May; 29(5):523-9. PubMed ID: 12779282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate.
    Kinoshita M; Baba K; Nagayasu A; Yamabe K; Shimooka T; Takeichi Y; Azuma M; Houchi H; Minakuchi K
    J Pharm Sci; 2002 Feb; 91(2):362-70. PubMed ID: 11835196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorption of a poorly water-soluble drug onto porous calcium silicate by the sealed heating method.
    Kawano Y; Chen S; Hanawa T
    Int J Pharm; 2020 Sep; 587():119637. PubMed ID: 32663587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder.
    Lee HL; Vasoya JM; Cirqueira ML; Yeh KL; Lee T; Serajuddin AT
    Mol Pharm; 2017 Apr; 14(4):1278-1291. PubMed ID: 28245127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate.
    Yuasa H; Asahi D; Takashima Y; Kanaya Y; Shinozawa K
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2327-31. PubMed ID: 7859331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.
    Sharma S; Sher P; Badve S; Pawar AP
    AAPS PharmSciTech; 2005 Dec; 6(4):E618-25. PubMed ID: 16408863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting physical stability of ternary amorphous solid dispersions using specific mechanical energy in a hot melt extrusion process.
    Hanada M; Jermain SV; Lu X; Su Y; Williams RO
    Int J Pharm; 2018 Sep; 548(1):571-585. PubMed ID: 30006310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate).
    Takashima Y; Yuasa H; Kanaya Y; Nomura I; Shinozawa K
    Int J Pharm; 1999 Sep; 187(1):125-35. PubMed ID: 10502619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
    Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
    Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS).
    Agarwal V; Siddiqui A; Ali H; Nazzal S
    Int J Pharm; 2009 Jan; 366(1-2):44-52. PubMed ID: 18832019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P
    Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates.
    Hailu SA; Bogner RH
    J Pharm Sci; 2011 Apr; 100(4):1503-15. PubMed ID: 24081473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
    Forster A; Hempenstall J; Tucker ; Rades T
    Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.
    Bahl D; Hudak J; Bogner RH
    Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
    Penumetcha SS; Gutta LN; Dhanala H; Yamili S; Challa S; Rudraraju S; Rudraraju S; Rudraraju V
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1609-20. PubMed ID: 26925514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.